107 Views | 44 Downloads
Dr. Harvey has served as a consultant to Amgen and GlaxoSmithKline and has received institutional research funding from Abbisko Therapeutics, AbbVie, Actuate, Alkermes, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Boston Biomedical, Calithera, FujiFilm, Genmab, GlaxoSmithKline, Infinity, InhibRx, Janssen, Lycera, Merck, Mersana, Meryx, Nektar, Pfizer, Puma Biotechnology, Rapt Therapeutics, Regeneron, Rgenix, Sanofi, Seattle Genetics, Sutro, Takeda, and Xencor. Mr. Begue and Mr. Raine have no conflicts of interest to disclose. Dr. Yabroff has served on the health equity advisory board of Flatiron Health.
© 2022 Harborside™